Stewart M G, Coker N J, Jenkins H A, Manolidis S, Bautista M H
Bobby R. Alford Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, TX 77030, USA.
Otolaryngol Head Neck Surg. 2000 Nov;123(5):527-32. doi: 10.1067/mhn.2000.110364.
The goal was to measure quality of life (QOL) and hearing-specific functional status before and after treatment of conductive hearing loss (CHL).
A prospective, longitudinal, outcomes-based study was performed at an academic medical center.
Mean baseline QOL scores in CHL patients were comparable with those of the general population. Audiometric studies indicated significant improvements in hearing threshold in all treated patients. There was no significant improvement in mean global QOL scores after treatment of CHL, although there was little room for improvement over baseline. The hearing-specific instrument did demonstrate significant improvements in emotional and social/situational hearing status after treatment. Patients treated with hearing aids had poorer baseline QOL and hearing status than patients treated with surgery and tended to show declines in QOL and only partial improvement in hearing-specific functional status after treatment.
Treatment of CHL resulted in improvements in hearing-specific functional status, although changes were difficult to detect with a global QOL instrument.
本研究旨在测量传导性听力损失（CHL）治疗前后的生活质量（QOL）和听力特异性功能状态。
在一所学术医疗中心进行了一项前瞻性、纵向、基于结果的研究。
CHL患者的平均基线QOL评分与普通人群相当。听力测试研究表明，所有接受治疗的患者听力阈值均有显著改善。CHL治疗后，平均总体QOL评分无显著改善，尽管相较于基线水平，提升空间不大。听力特异性指标在治疗后确实显示出情绪及社交/情境性听力状态有显著改善。接受助听器治疗的患者基线QOL和听力状态比接受手术治疗的患者差，治疗后QOL往往下降，听力特异性功能状态仅部分改善。
CHL治疗可改善听力特异性功能状态，尽管总体QOL指标难以检测到这种变化。
